Lung Cancer and Interstitial Lung Diseases: A Systematic Review | Zendy

Kostas Archontogeorgis | Zendy; Paschalis Steiropoulos | Zendy; Αrgyris Τzouvelekis | Zendy; Evangelia Nena | Zendy; Demosthenes Bouros | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lung Cancer and Interstitial Lung Diseases: A Systematic Review

Author(s) -

Kostas Archontogeorgis,

Paschalis Steiropoulos,

Αrgyris Τzouvelekis,

Evangelia Nena,

Demosthenes Bouros

Publication year - 2012

Publication title -

pulmonary medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.528

H-Index - 30

eISSN - 2090-1836

pISSN - 2090-1844

DOI - 10.1155/2012/315918

Subject(s) - medicine , lung cancer , sarcoidosis , pathology , lung , rheumatoid arthritis , dermatomyositis , interstitial lung disease , polymyositis , asbestosis , silicosis , immunology

Interstitial lung diseases (ILDs) represent a heterogeneous group of more than two hundred diseases of either known or unknown etiology with different pathogenesis and prognosis. Lung cancer, which is the major cause of cancer death in the developed countries, is mainly attributed to cigarette smoking and exposure to inhaled carcinogens. Different studies suggest a link between ILDs and lung cancer, through different pathogenetic mechanisms, such as inflammation, coagulation, dysregulated apoptosis, focal hypoxia, activation, and accumulation of myofibroblasts as well as extracellular matrix accumulation. This paper reviews current evidence on the association between lung cancer and interstitial lung diseases such as idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis, dermatomyositis/polymyositis, rheumatoid arthritis, systemic lupus erythematosus, and pneumoconiosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research